Inflammatory bowel disease, or IBD, is becoming more common worldwide and now affects millions of people. It is a condition where the digestive system becomes inflamed over a long period of time.
This inflammation can damage the intestinal wall and lead to symptoms such as frequent diarrhea, stomach pain, and extreme tiredness. Many patients struggle to find treatments that work well, which makes the search for new therapies very important.
A new study published in Stem Cell Reports by researchers at the University of Tokyo introduces a new way to study and treat this disease. The scientists developed a model of the human intestine using stem cells. These cells were grown in the laboratory to behave like real intestinal tissue.
To study IBD, the researchers created conditions that mimic the disease. They exposed the lab-grown cells to a protein known to trigger inflammation in patients. This caused the cells to become damaged and die, similar to what happens in people with IBD.
With this model in place, the researchers tested thousands of different compounds to find one that could protect the cells. This process, known as high-throughput screening, allows scientists to quickly test many possible treatments. In this study, around 3,500 substances were examined.
Among these, one compound showed strong protective effects. This compound, called glycyrrhizin, is found in black licorice. The researchers observed that it reduced both inflammation and cell damage in the intestinal model.
To strengthen their findings, the scientists also tested the compound in mice with IBD. The results showed that glycyrrhizin reduced inflammation and helped protect the intestinal lining. This suggests that the compound may work in living organisms, not just in lab-grown cells.
The study highlights the value of using human-like models in research. Traditional methods often rely on animal models, which do not always fully represent human biology. By using stem cell-derived tissue, scientists can better understand how diseases affect the human body.
Despite these promising results, there are still important questions to answer. The study does not yet prove that glycyrrhizin will work safely or effectively in humans. Clinical trials are needed to confirm whether the compound can be used as a treatment.
Another consideration is dosage and safety. Natural substances are not always harmless, especially when used in large amounts or over long periods. Careful testing will be needed to ensure that any new treatment is both safe and effective.
Overall, this research offers a hopeful step forward. It suggests that new technologies can help discover better treatments for difficult diseases like IBD. While more work is needed, the findings provide a strong foundation for future studies and possible new therapies.
If you care about gut health, please read studies about how probiotics can protect gut health ,and Mycoprotein in diet may reduce risk of bowel cancer and improve gut health.
For more health information, please see recent studies about how food additives could affect gut health, and the best foods for gut health.
Source: University of Tokyo.
